UNSPSC 51385602: Aspirin

This classification denotes a cyclooxygenase inhibitor with the molecular formula C9H7O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E62HT5S2E9, and which bears US NIH Compound Identifier 23666729. Most nations schedule aspirin under HS 29182200 and SITC 51393. As of Q4 2014, ASPIRIN remains the US FDA Preferred Term for this commodity. Aspirin bears US NLM identifiers UMLS ID C0004057 and NCI Concept Code C287. SMILES: CC(=O)OC1=CC=CC=C1C(=O)[O-].

UNSPSC 51385602 Aspirin is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though the recent opportunities block shows a mismatch between the code's nominal scope and actual solicitation activity. The single recent opportunity posted under this code — Seminole County, Florida's IFB for Naloxone and Safe Drug Deactivation Systems — involves emergency-response pharmaceuticals and harm-reduction equipment rather than aspirin or general analgesics. The county solicitation specifies 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems for annual procurement with quarterly deliveries to the Seminole County Community Health Building. Vendors must include all shipping and delivery costs in their bids, meet E-Verify and drug-free workplace certification requirements, carry workers' compensation and commercial general liability insurance, and accept a three-month probationary period with at-will termination rights. The contract carries a two-year initial term plus one optional one-year renewal and is potentially FEMA-funded, triggering compliance with the Clean Air Act and Federal Water Pollution Control Act.

The geographic activity visible under this code is limited to Florida based on the single recent posting. Seminole County's IFB (number IFB60459723LAS) posted June 30, 2026 with a response deadline of July 26, 2023 — a date inconsistency in the source material that suggests the solicitation record may be stale or corrupted. No other state and local opportunities appear in the recent-opportunities block, indicating minimal current activity under this code designation. The mismatch between the code's aspirin title and the actual procurement (emergency naloxone and drug deactivation systems) suggests either miscoding by the issuing body or that this code has drifted from its nominal commodity scope in state procurement practice. Bidders should verify current coding against active solicitations before investing pursuit effort.